# A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

> **NCT00666705** · PHASE4 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Maraviroc
- **DRUG:** Raltegravir
- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT00666705
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666705, "A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00666705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*